Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ultra-rapid Opiate Detoxification Using Deep Sedation and Prior Oral Buprenorphine Preparation.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01008072
Recruitment Status : Unknown
Verified November 2009 by Assaf-Harofeh Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : November 5, 2009
Last Update Posted : November 5, 2009
Sponsor:
Information provided by:
Assaf-Harofeh Medical Center

Brief Summary:
The methods of detoxification under general anesthesia have been criticized because of limited data on safety and long-term follow-up. Premedication with buprenorphine has been advocated to improve safety. In current study we want to evaluate the importance of buprenorphine preparation in rapid opioid detoxification process, under general anesthesia.

Condition or disease
Opioid Addiction

Layout table for study information
Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Case-Control
Time Perspective: Retrospective
Study Start Date : December 2009
Estimated Primary Completion Date : December 2009

Resource links provided by the National Library of Medicine


Group/Cohort
without buprenorphine preparation
with buprenorphine preparation




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All opioid addicted patients who wants to undergo rapid detoxification under general anesthesia.
Criteria

Inclusion Criteria:

  • Opioid addiction

Exclusion Criteria:

  • Age < 18 Pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01008072


Contacts
Layout table for location contacts
Contact: Murat Bahar, MD 97289778080 muratbahar@asaf.health.gov.il

Locations
Layout table for location information
Israel
Anesthesiology department, Assaf-Harofeh MC
Beer-Yaakov, Zrifin, Israel, 70300
Contact: Murat Bahar, MD    97289778080    muratbahar@asaf.health.gov.il   
Principal Investigator: Murat Bahar, MD         
Sponsors and Collaborators
Assaf-Harofeh Medical Center
Layout table for additonal information
Responsible Party: Murat Bahar, Assaf-Harofeh MC
ClinicalTrials.gov Identifier: NCT01008072    
Other Study ID Numbers: 173/09
First Posted: November 5, 2009    Key Record Dates
Last Update Posted: November 5, 2009
Last Verified: November 2009
Additional relevant MeSH terms:
Layout table for MeSH terms
Opioid-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders